MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13024-023-00646-z

Медицинская библиотека · Molecular neurodegeneration · 2023

TDP-43-regulated cryptic RNAs accumulate in Alzheimer's disease brains.

Estades Ayuso Virginia, Pickles Sarah, Todd Tiffany, Yue Mei, Jansen-West Karen, Song Yuping, González Bejarano Jesús, Rawlinson Bailey, DeTure Michael, Graff-Radford Neill R, Boeve Bradley F, Knopman David S, Petersen Ronald C, Dickson Dennis W, Josephs Keith A, Petrucelli Leonard, Prudencio Mercedes

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Inclusions of TAR DNA-binding protein 43 kDa (TDP-43) has been designated limbic-predominant, age-related TDP-43 encephalopathy (LATE), with or without co-occurrence of Alzheimer's disease (AD). Approximately, 30-70% AD cases present TDP-43 proteinopathy (AD-TDP), and a greater disease severity compared to AD patients without TDP-43 pathology. However, it remains unclear to what extent TDP-43 dysfunction is involved in AD pathogenesis.

METHODS

To investigate whether TDP-43 dysfunction is a prominent feature in AD-TDP cases, we evaluated whether non-conserved cryptic exons, which serve as a marker of TDP-43 dysfunction in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), accumulate in AD-TDP brains. We assessed a cohort of 192 post-mortem brains from three different brain regions: amygdala, hippocampus, and frontal cortex. Following RNA and protein extraction, qRT-PCR and immunoassays were performed to quantify the accumulation of cryptic RNA targets and phosphorylated TDP-43 pathology, respectively.

RESULTS

We detected the accumulation of misspliced cryptic or skiptic RNAs of STMN2, KCNQ2, UNC13A, CAMK2B, and SYT7 in the amygdala and hippocampus of AD-TDP cases. The topographic distribution of cryptic RNA accumulation mimicked that of phosphorylated TDP-43, regardless of TDP-43 subtype classification. Further, cryptic RNAs efficiently discriminated AD-TDP cases from controls.

CONCLUSIONS

Overall, our results indicate that cryptic RNAs may represent an intriguing new therapeutic and diagnostic target in AD, and that methods aimed at detecting and measuring these species in patient biofluids could be used as a reliable tool to assess TDP-43 pathology in AD. Our work also raises the possibility that TDP-43 dysfunction and related changes in cryptic splicing could represent a common molecular mechanism shared between AD-TDP and FTLD-TDP.

Для цитирования: Estades Ayuso Virginia, Pickles Sarah, Todd Tiffany, Yue Mei, Jansen-West Karen, Song Yuping, González Bejarano Jesús, Rawlinson Bailey, DeTure Michael, Graff-Radford Neill R, Boeve Bradley F, Knopman David S, Petersen Ronald C, Dickson Dennis W, Josephs Keith A, Petrucelli Leonard, Prudencio Mercedes. TDP-43-regulated cryptic RNAs accumulate in Alzheimer's disease brains.. Molecular neurodegeneration. 2023. DOI: 10.1186/s13024-023-00646-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.